You could say we've spurred a national debate here with the patient-led push for improved diabetes technology. But the term "debate" implies argument, and happily, most people seem to agree that "more is more": the more attention paid to developing better technology, the more often better technology will be developed.
Check out this blogosphere/media coverage of Adaptive Path's answer to my call for cooler diabetes devices:
NPR's Future Tense
JDRF Artificial Pancreas Project
+ more to come?
Keep talking, people. It seems we've finally pricked up the consumer design world's ears.
** UPDATE: See a new follow-up blog post today on Adaptive Path's vision of the future.**
Hey there, Diabetes Friends! Welcome back to our weekly advice column, Ask D'Mine. I'm your friendly host, Wil Dubois -- a longtime type 1 diagnosed as an adult who happens to write about diabetes and work as a clinical diabetes specialist in New...
It's always good to keep in touch with the leadership at big diabetes companies, to understand their POV.That's why we were happy to be introduced to Camille Lee in April at the Novo-sponsored DOC forum in Phoenix, that brought a couple dozen diab...
It all began with a racecar driver in Minnesota. About a decade ago, a marketing businessman met a D-Dad in the Twin Cities area with a T1D son. That father was Bill Hansen and his son, Todd Hansen, was a professional stock car driver in the AR...
Of course we've been closely following the hot topic of high insulin prices, hoping to find some answers about how to best address this quagmire. We've reported here about The Human Cost of High Insulin Prices and heard the Insulin Makers' Respons...
Hey PWDs, ever feel like you're channeling The Walking Dead? Props once again to the creative Jon Carter, a veteran freelance cartoonist drawing for numerous newspapers, online publications and corporate clients for more than 20 years. He ...